Therapeutics Company Reports Positive Topline Data From Major Clinical Trial
Positive Topline Data from Regulus Therapeutics' Phase 1b MAD Clinical Trial of RGLS8429 for ADPKD.
Disclaimer: The information provided in this article is for educational purposes only and should not be construed as medical or investment advice. Please consult with a healthcare professional or financial advisor for personalized guidance.
Real-time information is available daily at https://stockregion.net